NICE guidance on medical cannabis products criticised as ‘restrictive and negative’

Mike Barnes, a consultant neurologist and chair of the Medical Cannabis Clinicians Society

Source: Courtesy of Mike Barnes

Consultant neurologist Mike Barnes says the draft NICE guidance means the chances of NHS doctors getting approval to prescribe cannabis-based medical products has diminished to “basically zero”

Draft guidance from the National Institute for Health and Care Excellence on cannabis-based medical products (CBMPs) has been described as “restrictive and negative” by a doctor who has campaigned for greater access to medical cannabis.

Mike Barnes, a consultant neurologist and chair of the Medical Cannabis Clinicians’ Society, said the guidance would make it more difficult for doctors to issue prescriptions for medical cannabis.

The guidance, published on 8 August 2019, is the first to be published since medical cannabis was legalised in November 2018. As well as calling for more trials in CBMPs, NICE says patients with chronic pain should

... read more at: https://www.pharmaceutical-journal.com/news-and-analysis/news/nice-guidance-on-medical-cannabis-products-criticised-as-restrictive-and-negative/20206930.article

by

Leave a Reply